Press Releases Prestige Consumer Healthcare Inc. Deutsche Boerse AG

Equities

PBV

US74112D1019

Delayed Deutsche Boerse AG Other stock markets 03:01:50 2024-07-03 am EDT			5-day change	1st Jan Change
63 ^EUR	+0.80%		-2.33%	+13.51%

Jun. 21	DA Davidson Upgrades Prestige Consumer Healthcare to Buy From Neutral, Adjusts Price Target to $93 From $65	MT
May. 15	Sector Update: Health Care Stocks Rise Pre-Bell Wednesday	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results	Jul. 02	GL
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference	Jun. 06	GL
Prestige Consumer Healthcare : Insider Trading Policy	May. 20	PU
Prestige Consumer Healthcare : Q4 2024 Prestige Consumer Healthcare Inc. Earnings Conference Call Presentation	May. 15	PU
Prestige Consumer Healthcare: Fiscal Q4 Earnings Snapshot	May. 14	AQ
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results	May. 14	GL
Prestige Consumer Healthcare : Clawback Policy	Apr. 25	PU
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results	Apr. 25	GL
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag	Apr. 03	GL
Prestige Consumer Healthcare : Consumer Analyst Group of New York (CAGNY) 2024 Luncheon Presentation	Mar. 07	PU
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot	Feb. 08	AQ
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results	Feb. 08	GL
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	Feb. 02	GL
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	Feb. 02	AQ
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	Jan. 10	GL
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	Jan. 10	AQ
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene	Dec. 22	GL
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene	Nov. 24	GL
Prestige Consumer Healthcare : Q2 2024 Prestige Consumer Healthcare Inc. Earnings Conference Call Presentation	Nov. 02	PU
Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot	Nov. 02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Prestige Consumer Healthcare Inc. Deutsche Boerse AG

Equities

PBV

US74112D1019

Press Releases

Filters